Evidence map›Paper›PMID 39157733›Full record

ReviewInternational journal of nanomedicine2024

Strategies for Targeting Peptide-Modified Exosomes and Their Applications in the Lungs.

Min Qiu, Jinru Zou, Zheng Yang, Dan Yang, Rui Wang, Haie Guo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of nanomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Min Qiu *College of Veterinary Medicine, Inner Mongolia Agricultural University, Inner Mongolia, People's Republic of China.
Jinru Zou *College of Pharmacy, Baotou Medical College, Baotou, People's Republic of China.
Zheng YangThe First Affiliated Hospital, Baotou Medical College, Baotou, People's Republic of China.
Dan YangCollege of Pharmacy, Baotou Medical College, Baotou, People's Republic of China.
Rui WangCollege of Veterinary Medicine, Inner Mongolia Agricultural University, Inner Mongolia, People's Republic of China.
Haie GuoCollege of Veterinary Medicine, Inner Mongolia Agricultural University, Inner Mongolia, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exosomes belong to a subgroup of extracellular vesicles secreted by various cells and are involved in intercellular communication and material transfer. In recent years, exosomes have been used as drug delivery carriers because of their natural origin, high stability, low immunogenicity and high engineering ability. However, achieving targeted drug delivery with exosomes remains challenging. In this paper, a phage display technology was used to screen targeted peptides, and different surface modification strategies of targeted peptide exosomes were reviewed. In addition, the application of peptide-targeted exosomes in pulmonary diseases was also summarised.

Indexed as

Drug Delivery SystemsExosomesLungPeptidesAnimalsCell Surface Display TechniquesDrug CarriersHumansLung DiseasesDrug CarriersPeptidesexosomelungtargeted deliverytargeted peptide modification

Identifiers

PMID39157733
PMCPMC11328869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.